1.
Bioconductor: open software development for computational biology and bioinformatics
Robert
C
Gentleman,
Vincent
J
Carey,
Douglas
M
Bates,
Ben
Bolstad,
Marcel
Dettling,
Sandrine
Dudoit,
Byron
Ellis,
Laurent
Gautier,
Yongchao
Ge,
Jeff
Gentry,
Kurt
Hornik,
Torsten
Hothorn,
Wolfgang
Huber,
Stefano
Iacus,
Rafael
Irizarry,
Friedrich
Leisch,
Cheng
Li,
Martin
Maechler,
Anthony
J
Rossini,
Gunther
Sawitzki,
Colin
Smith,
Gordon
Smyth,
Luke
Tierney,
Jean
YH
Yang,
Jianhua
Zhang
Genome Biology 2004, 5 :R80 (15 September 2004)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
A detailed description of the aims and methods of the Bioconductor project, an initiative for the collaborative creation of extensible software for computational biology and bioinformatics.
2.
What does the concept of the stem cell niche really mean today?
Arthur
D
Lander,
Judith
Kimble,
Hans
Clevers,
Elaine
Fuchs,
Didier
Montarras,
Margaret
Buckingham,
Anne
L
Calof,
Andreas
Trumpp,
Thordur
Oskarsson
BMC Biology 2012, 10 :19 (9 March 2012)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
How do current researchers view the stem cell niche? Eight experts from different fields provide their perspective, and ask how stem cells evolve in such an environment, launching a new Forum article type within the cross-journal collection on stem cells.
3.
Coffee consumption modifies risk of estrogen-receptor negative breast cancer
Jingmei
Li,
Petra
Seibold,
Jenny
Chang-Claude,
Dieter
Flesch-Janys,
Jianjun
Liu,
Kamila
Czene,
Keith
Humphreys,
Per
Hall
Breast Cancer Research 2011, 13 :R49 (14 May 2011)
Abstract | Full text | PDF | PubMed | F1000 Biology
|
Editor’s summary
A Swedish study finds that a high daily intake of coffee is associated with a statistically significant decrease in estrogen receptor-negative breast cancer among postmenopausal women.
4.
The aging epigenome: DNA methylation from the cradle to the grave
Marc
Winnefeld,
Frank
Lyko
Genome Biology 2012, 13 :165 (30 July 2012)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
Frank Lyko and Marc Winnefeld highlight a new survey of age-related epigenetic changes in newborn and centenarian methylomes
5.
The Drosophila methyl-DNA binding protein MBD2/3 interacts with the NuRD complex via p55 and MI-2
Joachim
Marhold,
Alexander
Brehm,
Katja
Kramer
BMC Molecular Biology 2004, 5 :20 (29 October 2004)
Abstract | Full text | PDF | PubMed
6.
Serum microRNAs as non-invasive biomarkers for cancer
Jan
C
Brase,
Daniela
Wuttig,
Ruprecht
Kuner,
Holger
Sültmann
Molecular Cancer 2010, 9 :306 (26 November 2010)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
7.
Comparison of normalization methods for Illumina BeadChip HumanHT-12 v3
Ramona
Schmid,
Patrick
Baum,
Carina
Ittrich,
Katrin
Fundel-Clemens,
Wolfgang
Huber,
Benedikt
Brors,
Roland
Eils,
Andreas
Weith,
Detlev
Mennerich,
Karsten
Quast
BMC Genomics 2010, 11 :349 (2 June 2010)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
8.
Conditional gene expression systems in the transgenic rat brain
Kai
Schönig,
Tillmann
Weber,
Ariana
Frömmig,
Lena
Wendler,
Brigitte
Pesold,
Dominik
Djandji,
Hermann
Bujard,
Dusan
Bartsch
BMC Biology 2012, 10 :77 (3 September 2012)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
The advantages of rats over mice for biomedical research have to date been offset by a dearth of proven methods for their genetic manipulation. Addressing this deficit, Bartsch and coauthors develop transgenic rats with inducible reporter gene expression in forebrain neurons.
9.
The head-regeneration transcriptome of the planarian Schmidtea mediterranea
Thomas
Sandmann,
Matthias
C
Vogg,
Suthira
Owlarn,
Michael
Boutros,
Kerstin
Bartscherer
Genome Biology 2011, 12 :R76 (16 August 2011)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
Next generation sequencing was used to investigate the transcriptome of head regeneration in the planarian Schmidtea mediterranea
10.
Targeted high throughput sequencing in clinical cancer Settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity
Martin
Kerick,
Melanie
Isau,
Bernd
Timmermann,
Holger
Sültmann,
Ralf
Herwig,
Sylvia
Krobitsch,
Georg
Schaefer,
Irmgard
Verdorfer,
Georg
Bartsch,
Helmut
Klocker,
Hans
Lehrach,
Michal
R
Schweiger
BMC Medical Genomics 2011, 4 :68 (29 September 2011)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
11.
RNAi-based validation of antibodies for reverse phase protein arrays
Heiko
A
Mannsperger,
Stefan
Uhlmann,
Christian
Schmidt,
Stefan
Wiemann,
Özgür
Sahin,
Ulrike
Korf
Proteome Science 2010, 8 :69 (23 December 2010)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
12.
Body fluid derived exosomes as a novel template for clinical diagnostics
Sascha
Keller,
Johannes
Ridinger,
Anne-Kathleen
Rupp,
Johannes
WG
Janssen,
Peter
Altevogt
Journal of Translational Medicine 2011, 9 :86 (8 June 2011)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
13.
Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification
Jan
C
Brase,
Heiko
Mannsperger,
Holger
Fröhlich,
Stephan
Gade,
Christian
Schmidt,
Stefan
Wiemann,
Tim
Beissbarth,
Thorsten
Schlomm,
Holger
Sültmann,
Ulrike
Korf
Proteome Science 2010, 8 :36 (22 June 2010)
Abstract | Full text | PDF | PubMed
14.
Concurrent detection of autolysosome formation and lysosomal degradation by flow cytometry in a high-content screen for inducers of autophagy
Phillip
Hundeshagen,
Anne
Hamacher-Brady,
Roland
Eils,
Nathan
R
Brady
BMC Biology 2011, 9 :38 (2 June 2011)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
There is much interest in activating autophagy, by which cells deliver their own contents to the lysosomal system, in cancer therapy. Nathan Brady and colleagues report a flow cytometric method whereby drug candidates may be screened for effects on separate steps in the process.
15.
The receptor RAGE: Bridging inflammation and cancer
Astrid
Riehl,
Julia
Németh,
Peter
Angel,
Jochen
Hess
Cell Communication and Signaling 2009, 7 :12 (8 May 2009)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
16.
Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study
Rebecca
Ritte,
Annekatrin
Lukanova,
Franco
Berrino,
Laure
Dossus,
Anne
Tjønneland,
Anja
Olsen,
Thure
Overvad,
Kim
Overvad,
Françoise
Clavel-Chapelon,
Agnès
Fournier,
Guy
Fagherazzi,
Sabine
Rohrmann,
Birgit
Teucher,
Heiner
Boeing,
Krasimira
Aleksandrova,
Antonia
Trichopoulou,
Pagona
Lagiou,
Dimitrios
Trichopoulos,
Domenico
Palli,
Sabina
Sieri,
Salvatore
Panico,
Rosario
Tumino,
Paolo
Vineis,
José
Quirós,
Genevieve
Buckland,
Maria-José
Sánchez,
Pilar
Amiano,
María-Dolores
Chirlaque,
Eva
Ardanaz,
Malin
Sund
et al.
Breast Cancer Research 2012, 14 :R76 (14 May 2012)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
17.
Molecular biology of cantharidin in cancer cells
Rolf
Rauh,
Stefan
Kahl,
Herbert
Boechzelt,
Rudolf
Bauer,
Bernd
Kaina,
Thomas
Efferth
Chinese Medicine 2007, 2 :8 (4 July 2007)
Abstract | Full text | PDF | PubMed
18.
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
Anna
Mulligan,
Fergus
J
Couch,
Daniel
Barrowdale,
Susan
M
Domchek,
Diana
Eccles,
Heli
Nevanlinna,
Susan
J
Ramus,
Mark
Robson,
Mark
Sherman,
Amanda
B
Spurdle,
Barbara
Wappenschmidt,
Andrew
Lee,
Lesley
McGuffog,
Sue
Healey,
Olga
M
Sinilnikova,
Ramunas
Janavicius,
Thomas
vO
Hansen,
Finn
C
Nielsen,
Bent
Ejlertsen,
Ana
Osorio,
Iván
Muñoz-Repeto,
Mercedes
Durán,
Javier
Godino,
Maroulio
Pertesi,
Javier
Benítez,
Paolo
Peterlongo,
Siranoush
Manoukian,
Bernard
Peissel,
Daniela
Zaffaroni,
Elisa
Cattaneo
et al.
Breast Cancer Research 2011, 13 :R110 (2 November 2011)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
19.
Exploring the link between MORF4L1 and risk of breast cancer
Griselda
Martrat,
Christopher
A
Maxwell,
Emiko
Tominaga,
Montserrat
Porta-de-la-Riva,
Núria
Bonifaci,
Laia
Gómez-Baldó,
Massimo
Bogliolo,
Conxi
Lázaro,
Ignacio
Blanco,
Joan
Brunet,
Helena
Aguilar,
Juana
Fernández-Rodríguez,
Sheila
Seal,
Anthony
Renwick,
Nazneen
Rahman,
Julia
Kühl,
Kornelia
Neveling,
Detlev
Schindler,
María
J
Ramírez,
María
Castellà,
Gonzalo
Hernández,
Douglas
F
Easton,
Susan
Peock,
Margaret
Cook,
Clare
T
Oliver,
Debra
Frost,
Radka
Platte,
D Gareth
Evans,
Fiona
Lalloo
et al.
Breast Cancer Research 2011, 13 :R40 (5 April 2011)
Abstract | Full text | PDF | PubMed
20.
DNA-vaccination via tattooing induces stronger humoral and cellular immune responses than intramuscular delivery supported by molecular adjuvants
Dana
Pokorna,
Ivonne
Rubio,
Martin
Müller
Genetic Vaccines and Therapy 2008, 6 :4 (7 February 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
The tattoo delivery of DNA vaccines is cost effective, induces a greater immune response, and is a more efficient delivery strategy for laboratory studies than intramuscular injection.
21.
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers
Antonis
C
Antoniou,
Karoline
B
Kuchenbaecker,
Penny
Soucy,
Jonathan
Beesley,
Xiaoqing
Chen,
Lesley
McGuffog,
Andrew
Lee,
Daniel
Barrowdale,
Sue
Healey,
Olga
M
Sinilnikova,
Maria
A
Caligo,
Niklas
Loman,
Katja
Harbst,
Annika
Lindblom,
Brita
Arver,
Richard
Rosenquist,
Per
Karlsson,
Kate
Nathanson,
Susan
Domchek,
Tim
Rebbeck,
Anna
Jakubowska,
Jan
Lubinski,
Katarzyna
Jaworska,
Katarzyna
Durda,
Elżbieta
Złowowcka-Perłowska,
Ana
Osorio,
Mercedes
Durán,
Raquel
Andrés,
Javier
Benítez,
Ute
Hamann
et al.
Breast Cancer Research 2012, 14 :R33 (20 February 2012)
Abstract | Full text | PDF | PubMed
22.
Triplex DNA-binding proteins are associated with clinical outcomes revealed by proteomic measurements in patients with colorectal cancer
Laura
D
Nelson,
Christian
Bender,
Heiko
Mannsperger,
Daniel
Buergy,
Patryk
Kambakamba,
Giridhar
Mudduluru,
Ulrike
Korf,
Dennis
Hughes,
Michael
W
Van Dyke,
Heike
Allgayer
Molecular Cancer 2012, 11 :38 (8 June 2012)
Abstract | Full text | PDF | PubMed
23.
Video Q&A: Excess body weight and cancer
Rudolf
Kaaks
BMC Medicine 2013, 11 :2 (3 January 2013)
Full text | PDF | PubMed
|
Editor’s summary
Rudolf Kaaks talks about types of cancers linked to the overweight and obesity epidemic, and advises that although weight loss may decrease the risk of developing cancer, ultimately prevention is better than the cure.
24.
Global expression analysis of the brown alga Ectocarpus siliculosus (Phaeophyceae) reveals large-scale reprogramming of the transcriptome in response to abiotic stress
Simon
M
Dittami,
Delphine
Scornet,
Jean-Louis
Petit,
Béatrice
Ségurens,
Corinne
Da Silva,
Erwan
Corre,
Michael
Dondrup,
Karl-Heinz
Glatting,
Rainer
König,
Lieven
Sterck,
Pierre
Rouzé,
Yves
Van de Peer,
J Mark
Cock,
Catherine
Boyen,
Thierry
Tonon
Genome Biology 2009, 10 :R66 (16 June 2009)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
The brown alga Ectocarpus siliculosus , unlike terrestrial plants, undergoes extensive reprogramming of its transcriptome during the acclimation to mild abiotic stress.
25.
Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study
Alina
Vrieling,
Rebecca
Hein,
Sascha
Abbas,
Andreas
Schneeweiss,
Dieter
Flesch-Janys,
Jenny
Chang-Claude
Breast Cancer Research 2011, 13 :R74 (26 July 2011)
Abstract | Full text | PDF | PubMed
26.
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
Frank
Westermann,
Daniel
Muth,
Axel
Benner,
Tobias
Bauer,
Kai-Oliver
Henrich,
André
Oberthuer,
Benedikt
Brors,
Tim
Beissbarth,
Jo
Vandesompele,
Filip
Pattyn,
Barbara
Hero,
Rainer
König,
Matthias
Fischer,
Manfred
Schwab
Genome Biology 2008, 9 :R150 (13 October 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
Differences in MYCN/c-MYC target gene expression are associated with distinct neuroblastoma subtypes and clinical outcome.
27.
Analysis of cell-based RNAi screens
Michael
Boutros,
Lígia
P
Brás,
Wolfgang
Huber
Genome Biology 2006, 7 :R66 (25 July 2006)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
cellHTS is a new method for the analysis and documentation of RNAi screens.
28.
MHC class I-related chain A and B ligands are differentially expressed in human cervical cancer cell lines
Susana
del Toro-Arreola,
Naela
Arreygue-Garcia,
Adriana
Aguilar-Lemarroy,
Angel
Cid-Arregui,
Miriam
Jimenez-Perez,
Jesse
Haramati,
Patricio
Barros-Nuñez,
Oscar
Gonzalez-Ramella,
Alicia
del Toro-Arreola,
Pablo
Ortiz-Lazareno,
Georgina
Hernandez-Flores,
Alejandro
Bravo-Cuellar,
Adrian
Daneri-Navarro,
Luis
F
Jave-Suarez
Cancer Cell International 2011, 11 :15 (1 June 2011)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
29.
Off-target effects of siRNA specific for GFP
Cordula
Tschuch,
Angela
Schulz,
Armin
Pscherer,
Wiebke
Werft,
Axel
Benner,
Agnes
Hotz-Wagenblatt,
Leticia
Barrionuevo,
Peter
Lichter,
Daniel
Mertens
BMC Molecular Biology 2008, 9 :60 (24 June 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
30.
Assisted reproductive techniques and the risk of anorectal malformations: a German case-control study
Nadine
Zwink,
Ekkehart
Jenetzky,
Eberhard
Schmiedeke,
Dominik
Schmidt,
Stefanie
Märzheuser,
Sabine
Grasshoff-Derr,
Stefan
Holland-Cunz,
Sandra
Weih,
Stuart
Hosie,
Peter
Reifferscheid,
Helen
Ameis,
Christina
Kujath,
Anke
Rißmann,
Florian
Obermayr,
Nicole
Schwarzer,
Enrika
Bartels,
Heiko
Reutter,
Hermann
Brenner,
Orphanet Journal of Rare Diseases 2012, 7 :65 (15 September 2012)
Abstract | Full text | PDF | PubMed
31.
Epstein-Barr virus genetics: talking about the BAC generation
Regina
Feederle,
Emmalene
J
Bartlett,
Henri-Jacques
Delecluse
Herpesviridae 2010, 1 :6 (7 December 2010)
Abstract | Full text | PDF | PubMed
32.
Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: The MARCIE Trial
Stephanie
E
Combs,
Lutz
Edler,
Iris
Burkholder,
Stefan
Rieken,
Daniel
Habermehl,
Oliver
Jäkel,
Thomas
Haberer,
Andreas
Unterberg,
Wolfgang
Wick,
Jürgen
Debus,
Renate
Haselmann
BMC Cancer 2010, 10 :615 (9 November 2010)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
33.
Concurrent epigenetic silencing of wnt/β -catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia
Evgeny
A
Moskalev,
Katrin
Luckert,
Ivan
A
Vorobjev,
Sergey
E
Mastitsky,
Aleena
A
Gladkikh,
Achim
Stephan,
Marita
Schrenk,
Kamil
D
Kaplanov,
Olga
B
Kalashnikova,
Oliver
Pötz,
Thomas
O
Joos,
Jörg
D
Hoheisel
BMC Cancer 2012, 12 :213 (6 June 2012)
Abstract | Full text | PDF | PubMed
34.
Integrative analysis of RUNX1 downstream pathways and target genes
Joëlle
Michaud,
Ken
M
Simpson,
Robert
Escher,
Karine
Buchet-Poyau,
Tim
Beissbarth,
Catherine
Carmichael,
Matthew
E
Ritchie,
Frédéric
Schütz,
Ping
Cannon,
Marjorie
Liu,
Xiaofeng
Shen,
Yoshiaki
Ito,
Wendy
H
Raskind,
Marshall
S
Horwitz,
Motomi
Osato,
David
R
Turner,
Terence
P
Speed,
Maria
Kavallaris,
Gordon
K
Smyth,
Hamish
S
Scott
BMC Genomics 2008, 9 :363 (31 July 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
35.
Functions, structure, and read-through alternative splicing of feline APOBEC3 genes
Carsten
Münk,
Thomas
Beck,
Jörg
Zielonka,
Agnes
Hotz-Wagenblatt,
Sarah
Chareza,
Marion
Battenberg,
Jens
Thielebein,
Klaus
Cichutek,
Ignacio
G
Bravo,
Stephen
J
O'Brien,
Martin
Lochelt,
Naoya
Yuhki
Genome Biology 2008, 9 :R48 (3 March 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
APOBEC3 (A3, Apolipoprotein B mRNA-editing catalytic polypeptide 3) genes in the genome of domestic cat (Felis catus) were identified and characterized
36.
Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study
Roger
L
Milne,
Mia
M
Gaudet,
Amanda
B
Spurdle,
Peter
A
Fasching,
Fergus
J
Couch,
Javier
Benítez,
José Ignacio
Arias Pérez,
M Pilar
Zamora,
Núria
Malats,
Isabel
dos Santos Silva,
Lorna
J
Gibson,
Olivia
Fletcher,
Nichola
Johnson,
Hoda
Anton-Culver,
Argyrios
Ziogas,
Jonine
Figueroa,
Louise
Brinton,
Mark
E
Sherman,
Jolanta
Lissowska,
John
L
Hopper,
Gillian
S
Dite,
Carmel
Apicella,
Melissa
C
Southey,
Alice
J
Sigurdson,
Martha
S
Linet,
Sara
J
Schonfeld,
D Michal
Freedman,
Arto
Mannermaa,
Veli-Matti
Kosma,
Vesa
Kataja
et al.
Breast Cancer Research 2010, 12 :R110 (31 December 2010)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
37.
Experimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer
Dmitriy
I
Dovzhanskiy,
Stefanie
M
Arnold,
Thilo
Hackert,
Ina
Oehme,
Olaf
Witt,
Klaus
Felix,
Nathalia
Giese,
Jens
Werner
BMC Cancer 2012, 12 :226 (8 June 2012)
Abstract | Full text | PDF | PubMed
38.
Molecular targeted therapies for breast cancer treatment
Claus
M
Schlotter,
Ulf
Vogt,
Heike
Allgayer,
Burkhard
Brandt
Breast Cancer Research 2008, 10 :211 (24 July 2008)
Abstract | Full text | PDF | PubMed
39.
Design and evaluation of genome-wide libraries for RNA interference screens
Thomas
Horn,
Thomas
Sandmann,
Michael
Boutros
Genome Biology 2010, 11 :R61 (15 June 2010)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
NEXT-RNAi allows the design and evaluation of genome-wide RNAi screens in any organism.
40.
Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer: the HIL trial
Vasileios
Askoxylakis,
Julien
Dinkel,
Monika
Eichinger,
Bram
Stieltjes,
Gregor
Sommer,
Ludwig
G
Strauss,
Antonia
Dimitrakopoulou-Strauss,
Annette
Kopp-Schneider,
Uwe
Haberkorn,
Peter
E
Huber,
Marc
Bischof,
Jürgen
Debus,
Christian
Thieke
Radiation Oncology 2012, 7 :157 (14 September 2012)
Abstract | Full text | PDF | PubMed
41.
MicroRNA expression after ionizing radiation in human endothelial cells
Mechthild
Wagner-Ecker,
Christian
Schwager,
Ute
Wirkner,
Amir
Abdollahi,
Peter
E
Huber
Radiation Oncology 2010, 5 :25 (26 March 2010)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
42.
Parental risk factors and anorectal malformations: systematic review and meta-analysis
Nadine
Zwink,
Ekkehart
Jenetzky,
Hermann
Brenner
Orphanet Journal of Rare Diseases 2011, 6 :25 (17 May 2011)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
43.
A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68 Ga-PET imaging of prostate cancer
Martin
Schäfer,
Ulrike
Bauder-Wüst,
Karin
Leotta,
Frederic
Zoller,
Walter
Mier,
Uwe
Haberkorn,
Michael
Eisenhut,
Matthias
Eder
EJNMMI Research 2012, 2 :23 (6 June 2012)
Abstract | Full text | PDF | PubMed
44.
Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma
Kari
Hemminki,
Xiangdong
Liu,
Asta
Försti,
Jianguang
Ji,
Jan
Sundquist,
Kristina
Sundquist
Journal of Hematology & Oncology 2012, 5 :59 (2 October 2012)
Abstract | Full text | PDF | PubMed
45.
Intensity-modulated radiotherapy of nasopharyngeal carcinoma: a comparative treatment planning study of photons and protons
Zahra
Taheri-Kadkhoda,
Thomas
Björk-Eriksson,
Simeon
Nill,
Jan
J
Wilkens,
Uwe
Oelfke,
Karl-Axel
Johansson,
Peter
E
Huber,
Marc
W
Münter
Radiation Oncology 2008, 3 :4 (24 January 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
46.
Preferred analysis methods for Affymetrix GeneChips revealed by a wholly defined control dataset
Sung
E
Choe,
Michael
Boutros,
Alan
M
Michelson,
George
M
Church,
Marc
S
Halfon
Genome Biology 2005, 6 :R16 (28 January 2005)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central | F1000 Biology
|
Editor’s summary
A 'spike-in' experiment for Affymetrix GeneChips is described that provides a defined dataset of 3,860 RNA species. A 'best route' combination of analysis methods is presented which allows detection of approximately 70% of true positives before reaching a 10% false discovery rate.
47.
Monitoring spindle orientation: Spindle position checkpoint in charge
Ayse
K
Caydasi,
Bashar
Ibrahim,
Gislene
Pereira
Cell Division 2010, 5 :28 (11 December 2010)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
48.
Intensity modulated radiotherapy (IMRT) in the treatment of children and Adolescents - a single institution's experience and a review of the literature
Florian
Sterzing,
Eva
M
Stoiber,
Simeon
Nill,
Harald
Bauer,
Peter
Huber,
Jürgen
Debus,
Marc
W
Münter
Radiation Oncology 2009, 4 :37 (23 September 2009)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
49.
Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells
Mert
Erkan,
Nadine
Weis,
Zheng
Pan,
Christian
Schwager,
Tamar
Samkharadze,
Xiaohua
Jiang,
Ute
Wirkner,
Nathalia
A
Giese,
Wilhelm
Ansorge,
Jürgen
Debus,
Peter
E
Huber,
Helmut
Friess,
Amir
Abdollahi,
Jörg
Kleeff
Molecular Cancer 2010, 9 :88 (23 April 2010)
Abstract | Full text | PDF | PubMed
50.
Cross-platform analysis of cancer microarray data improves gene expression based classification of phenotypes
Patrick
Warnat,
Roland
Eils,
Benedikt
Brors
BMC Bioinformatics 2005, 6 :265 (4 November 2005)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central